Nov. 15 Seminar on Health Sector Innovation

Details

Published on Thursday, 03 November 2011 19:09

The Health Sector Management Program and the Health Sector Management Alumni Association at Boston University School of Management proudly present:

New Patterns of Innovation: Integrated Models of Biopharma and Diagnostics

Tuesday, November 15, 2011, 6:00PM - 8:30PM Executive Leadership Center, Fourth Floor Dinning Space

Boston University School of Management 595 Commonwealth Avenue Boston, MA 02215

Guest Panelists:

Mike Nohaile, Ph.D., Global Head of Molecular Diagnostics, Novartis

Patrick F. Terry, Principal, Pricing and Market Access Practice, Scientia Advisors LLC.

Matthew F. McManus, MD, PhD, MBA, President and CEO, PrimeraDx

Moderator: Jeff Elton, PhD, CEO, The KEW Group

New therapeutic strategies are increasingly the result of insight from pathway biology, genetics, and genomics. This brings together therapeutics and diagnostics in a variety of new ways, supporting new business models, regulatory processes, and reimbursement strategies. While the goal is for patients to be the ultimate beneficiaries of these changes, the interests of pharma/biopharma companies, diagnostics companies, regulators, public reimbursement authorities, and private payers can be at odds. This program brings together considerations of science, strategy, business models, regulation, reimbursement, and clinical practice to explore current trends and future direction in the field.

Co-Sponsored by:

Boston University School of Management Health Sector Management Program; Health Sector Management Alumni Association; School of Public Health; Health Law Program; School of Medicine; Health Services Management Association; BioBusiness Organization